MDIC Annual Public Forum
MDIC Annual Public Forum

APF 2024: Shaping the Future of Real-World Evidence and AI in Healthcare

By Erica Freeze

The MDIC Annual Public Forum 2024 kicked off this week with experts from the National Evaluation System for health Technology (NEST), the Centers for Medicare and Medicaid Services (CMS), and the FDA. Topics included the future of real-world evidence (RWE) and the integration of AI into the healthcare ecosystem and how can we leverage emerging technologies to bring innovative and safer solutions to patients.

Continue reading

MEDICA & COMPAMED 2024: Adapted Hall Layout for Even Better Integration of Trade Fair and Ancillary Program

MEDICA 2024 and COMPAMED 2024 trade fairs in Düsseldorf, Germany attract more than 6,000 exhibitors from about 70 countries. These events are globally unique information and business platforms for the entire value chain of medical technology systems and products – including development and manufacturing. MEDICA and COMPAMED will take place from November 11 – 14, 2024.

Continue reading

nanotube technology
nanotube technology

Pusan National University Researchers Explore the Interplay Between High-Affinity DNA and Carbon Nanotubes

By MedTech Intelligence Staff

Single-walled carbon nanotubes (SWCNTs) hold promise for biomedicine and nanoelectronics, yet the functionalization with single-stranded DNA (ssDNA) remains a challenge. In a new study, researchers from Korea functionalized SWCNTs using high-affinity ssDNA sequences identified through high-throughput selection. They demonstrated the effectivity and stability of these constructs using molecular dynamics simulations. Machine-learning models were used to accurately predict patterns that govern ssDNA-SWCNT binding affinity. These findings provide valuable insights into the interactions between ssDNA and SWCNTs.

Continue reading

Doctor working on computer
Doctor working on computer

Benefits and Risks of CDSS To Prevent Medication Errors and Adverse Drug Events

By MedTech Intelligence Staff

A review paper from the Agency for Healthcare Research and Quality supports the benefits of computerized clinical decision support systems (CDSS) in reducing medication errors and adverse drug events, but also uncovered risks and unintended consequences that must be addressed to improve patient safety and implementation of next generation systems.

Continue reading